血清sTNFR1、ANGPTL8与冠状动脉粥样硬化性心脏病患者PCI术后预后的关系
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

湖北陈孝平科技发展基金会临床研究基金项目(CXPJJH12000005-07-60)


Relationship between serum sTNFR1, ANGPTL8 and prognosis of coronary heart disease patients after PCI
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨血清可溶性肿瘤坏死因子受体1(sTNFR1)、血管生成素样蛋白8(ANGPTL8)水平与冠状动脉粥样硬化性心脏病(CHD)患者经皮冠状动脉介入(PCI)术治疗预后情况的关系。方法 选取武汉科技大学附属天佑医院2022年4月—2023年10月收治的行PCI手术治疗的CHD患者80例为研究对象,依据术后随访12个月内不良心血管事件发生情况分为预后良好组(n=62)、预后不良组(n=18)。对比两组患者的临床资料及血清sTNFR1、ANGPTL8 水平。Logistic多因素回归分析法筛选影响CHD患者PCI术后预后不良的风险因素。受试者工作特征曲线(ROC)评估血清sTNFR1、ANGPTL8预测CHD患者PCI治疗预后不良的效能。结果 经临床评估,纳入的80例CHD患者中,预后不良的患者占比22.50%。与预后良好组相比,预后不良组冠状动脉狭窄率、冠状动脉病变支数、甘油三酯(TG)、sTNFR1、ANGPTL8水平较高,差异具有统计学意义(P<0.05)。Logistic回归分析结果显示,冠状动脉病变支数(OR=1.895)、sTNFR1(OR=1.779)、ANGPTL8(OR=1.747)是CHD患者PCI治疗后预后不良的独立风险因素。ROC曲线显示,血清sTNFR1、ANGPTL8预测CHD患者PCI治疗后预后不良的敏感度分别为87.60%、84.50%,特异度分别为68.50%、65.20%,曲线下面积(AUC)分别为0.872、0.868,二者联合预测的灵敏度、特异度及AUC(90.50%、72.60%、0.905)均高于以上单一指标。结论 血清sTNFR1、ANGPTL8是CHD患者PCI治疗后预后不良的独立影响因素,且二者联合具有较高的预测效能,可作为辅助评估PCI预后情况的敏感指标

    Abstract:

    Objective To explore the relationship between the levels of serum soluble tumor necrosis factor receptor 1 (sTNFR1) and angiopoietin-like protein 8 (ANGPTL8) and the prognosis of patients with coronary atherosclerotic heart disease (CHD) after percutaneous coronary intervention (PCI). Methods A total of 80 patients with CHD who underwent PCI at Tianyou Hospital, Wuhan University of Science and Technology from April 2022 to October 2023 were selected as the research subjects. According to the occurrence of adverse cardiovascular events within 12 months after surgery, the 80 patients were divided into a good prognosis group and a poor prognosis group. The clinical data and serum sTNFR1 and ANGPTL8 levels of the two groups were compared. Logistic multivariate regression analysis was used to screen the risk factors for poor prognosis after PCI in CHD patients. The ROC curve was used to evaluate the efficacy of serum sTNFR1 and ANGPTL8 in predicting poor prognosis after PCI in CHD patients.Results After clinical assessment, among the 80 included CHD patients, 18 patients (22.50%) had a poor prognosis. Compared with the good prognosis group, the poor prognosis group had higher coronary artery stenosis rate, number of coronary artery lesions, triglyceride (TG), sTNFR1, and ANGPTL8 levels, and the differences were statistically significant (P<0.05). Logistic regression analysis showed that the number of coronary artery lesions (OR=1.895), sTNFR1 (OR=1.779), and ANGPTL8 (OR=1.747) were independent risk factors for poor prognosis after PCI in CHD patients. The ROC curve showed that the sensitivity of serum sTNFR1 and ANGPTL8 in predicting poor prognosis after PCI in CHD patients was 87.60% and 84.50%, respectively; the specificity was 68.50% and 65.20%, respectively; and the area under the curve was 0.872 and 0.868, respectively. The combined prediction of the two had higher sensitivity (90.50%), specificity (72.60%), and area under the curve (0.905) than the single indicators. Conclusion Serum sTNFR1 and ANGPTL8 are independent influencing factors for poor prognosis after PCI in CHD patients, and their combination has a high predictive efficacy and can be used as sensitive indicators for auxiliary assessment of PCI prognosis

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-11-20
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司